Success Story: From Neurodegenerative Disease Research to NIW Approval for a Neuroscience Researcher
Client’s Testimonial:
"I had a stellar experience with Chen Immigration. In addition to their professionalism and broad expertise, I would like to emphasize their genuine care in supporting my case, which clearly shows their dedication to understanding each client’s story more deeply than a simple lawyer-client relationship. Their meticulous work and sincerity made me feel secure about filing my case, and I cannot thank them enough for their help.”
On July 2nd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Doctoral Graduate Candidate in the Field of Neuroscience (Approval Notice).
General Field: Neuroscience
Position at the Time of Case Filing: Doctoral Graduate Candidate
Country of Origin: Turkey
State of Residence at the Time of Filing: Connecticut
Approval Notice Date: July 2nd, 2026
Processing Time: 1 month, 28 days (Premium Processing Requested)
Case Summary:
Our client received approval of an EB-2 National Interest Waiver (NIW) petition in just 59 days through Direct Premium Processing. Holding an M.Phil. in neuroscience, the client is conducting neuroscience research focused on better understanding the molecular mechanisms behind devastating neurodegenerative disorders. At the time of filing, the client was engaged in neuroscience research and sought to continue investigating abnormal RNA processing in human brain tissues and patient-derived neurons to identify potential therapeutic targets for conditions such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Rather than relying on a single accomplishment, we demonstrated that the client's work represented a sustained research effort addressing an area of clear national importance. The petition explained how improving scientific understanding of neurodegenerative diseases could support future therapeutic development for disorders that currently have limited treatment options while also aligning with broader U.S. priorities in neuroscience and biotechnology. We further highlighted that the research had attracted support from multiple highly competitive funding sources, reflecting independent confidence in the importance of the scientific questions being pursued.
To establish that the client was well positioned to advance this endeavor, we presented a combination of scholarly productivity, recognition, and professional trust. The client had authored 5 peer-reviewed journal articles (including 1 first-authored article) and 3 research abstracts. More importantly, these publications had been cited 326 times, demonstrating that other researchers were actively relying on the client's findings to advance their own work. Rather than treating citation numbers as an end in themselves, we explained how independent citation patterns and the continued use of the client's research reflected meaningful influence within the neuroscience community.
The petition further illustrated how the client's research had extended beyond publication by contributing methods, data, and scientific insights that other investigators incorporated into their own studies. This demonstrated that the client's work was helping advance ongoing research in neuroscience rather than remaining isolated within a single laboratory.
Additionally, due to its clear national importance, the client’s research has also been supported by the National Institutes of Health (NIH), the National Institute on Drug Abuse, the Muscular Dystrophy Association, the Brain and Behavior Research Foundation, the Whitehall Foundation, the Edward Mallinckrodt Jr. Foundation, and the NIH BRAIN Initiative. This funding is reserved solely for research directed at advancing the national interest, including advancing biomedical research to improve healthcare outcomes, with particular focus on the brain, mental health, broader neuroscience, and muscular conditions
By connecting the client's research achievements with the national significance of improving treatments for neurodegenerative diseases, Chen Immigration Law Associates demonstrated that the client satisfied the NIW framework and was well positioned to continue making valuable contributions in the United States.
We are delighted that this carefully prepared petition resulted in an approval without an RFE, and we wish the client continued success in advancing neuroscience research that may ultimately improve future treatments for neurological disorders.